RNA drug firm Arrowhead buys Alvos for delivery tech
RNA therapeutics developer Arrowhead Research has bought Alvos Therapeutics in the hope that peptide targeting technology will help it overcome delivery challenges.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs